What to Expect With HYQVIA

Here you'll find information on what to expect with HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Learn more about the HYQVIA Ramp-Up period, how to start treatment, and view real patient photos of what a HYQVIA infusion looks like.

The Ramp-Up Period1

To help you become comfortable with your treatment, after you receive the first dose of HYQVIA you will ramp up gradually. Your dose will eventually shift from 1 time a week to 1 time a month. Here is a typical schedule for a 4 week maintenance treatment schedule for starting HYQVIA.

Dose adjustment of HYQVIA may be necessary based on your clinical response.

Download Ramp-Up Schedule (PDF)
Download HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] infusions schedule

After the Ramp-Up: Once a Month!*

Once the ramp-up period has been completed, your treatment schedule is one infusion, one time a month. A second site can be used at the discretion of the physician and patient based on tolerability and total volume.

Dose adjustment of HYQVIA may be necessary based on your clinical response.

*Every 3-4 weeks

What It Looks Like When You Infuse With HYQVIA1

Following your infusion with HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], it's not uncommon to experience a temporary, soft swelling at the infusion site. This is due to the volume of fluid infused and may last 1 to 3 days after your infusion.

Example of soft swelling at the infusion site
Pre-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of infusion site prior to 500 mL infusion
Post-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of post-infusion swelling with 500 mL infusion
24 Hours After Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of infusion site 24 hours after 500 mL infusion

HYQVIA infused: 500 mL*

Pre-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of the infusion site prior to 225 mL infusion
Post-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of soft swelling at the infusion site with 225 mL infusion
24 Hours After Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of swelling at the infusion site after 24 hours with 225 mL infusion

HYQVIA infused: 225 mL*

Local infusion-site reactions such as mild or moderate pain, swelling, redness, and itching may also occur and generally go away within a few hours. Local reactions are less likely to occur after the first few infusions.

In the clinical trials there were no observable changes in the skin or subcutaneous tissue in almost 3000 infusions and maximum exposure of over 3 years.

Example of a mild local site reaction
Pre-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of pre-infusion
Post-Infusion
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] patient example of a mild local site reaction post infusion

HYQVIA infused: 494 mL*

*Volume infused as per the doctor's guidance based on this patient's specific clinical condition; it may be different for you.
2959 infusions and 188 subject-years.

What are the possible or reasonably likely side effects of HYQVIA?

After HYQVIA infusion a temporary, soft swelling may occur around the infusion site, which may last 1 to 3 days, due to the volume of fluid infused. Mild or moderate pain, redness, swelling, or itching may occur at the site of infusion and generally go away in a few hours. Local reactions are less likely after the first few infusions. The most common side effects of HYQVIA are headache, fatigue, nausea, fever, and vomiting.

Antibodies to the hyaluronidase component of HYQVIA were formed in some patients taking HYQVIA. It is not known if there is any long-term effect. In theory, these antibodies could react with your body's own PH20. PH20 is present in the male reproductive tract. So far, these antibodies have not been associated with increased or new side effects.



Please expand for Indication and Important Safety Information.

Selected Important Safety Information about HYQVIA
  • HYQVIA can cause blood clots. Call your healthcare professional if you have pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s), unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
  • Do not take HYQVIA if you are allergic to IgG, hyaluronidase, other blood products, human albumin (in the hyaluronidase solution), or have IgA deficiency with antibodies to IgA.
Indication and Important Safety Information
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution
  • HYQVIA is a liquid medicine containing immune globulin and Recombinant Human Hyaluronidase. HYQVIA contains IgG antibodies, collected from human plasma donated by healthy people. The antibodies help your body to fight off bacterial and viral infections. The hyaluronidase part of HYQVIA helps more of the immune globulin get absorbed into the body to fight infection.
  • HYQVIA is indicated for the treatment of Primary Immunodeficiency (PI) involving the humoral immune system in adults.
  • Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.
  • HYQVIA is infused under the skin (subcutaneous).
  • If you and your healthcare professional decide that home self-infusion of HYQVIA is right for you, then be sure you get instructions and training from your healthcare professional before using HYQVIA at home.
Important Safety Information
    • HYQVIA can cause blood clots.
    • Call your healthcare professional if you have pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s), unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
    • Your healthcare professional may perform blood tests regularly to check your IgG level.
    • With your consent, your healthcare professional may provide blood samples to Shire plc, to test for antibodies that may form against the hyaluronidase part of HYQVIA.
    • Do not infuse HYQVIA into or around an infected or red swollen area because it can cause infection to spread.
    • Talk to your healthcare professional if you become pregnant. Women who become pregnant during HYQVIA treatment are encouraged to enroll in the HYQVIA Pregnancy Registry by calling Medical Information at 1-866-424-6724.

    Do not take HYQVIA if you:

    • Are allergic to IgG, hyaluronidase, other blood products, or human albumin (in the hyaluronidase solution).
    • Have IgA deficiency with antibodies to IgA.

    HYQVIA can cause serious side effects. Call your healthcare professional or go to your emergency department right away if you get:

    • Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting or dizziness. These could be signs of a serious allergic reaction.
    • Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of swelling in your brain.
    • Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem.
    • Pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s). These could be signs of a blood clot.
    • Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem.
    • Chest pain or trouble breathing, blue lips or extremities. These could be signs of a lung problem.

    What are the possible or reasonably likely side effects of HYQVIA?

    • After HYQVIA infusion a temporary, soft swelling may occur around the infusion site, which may last 1 to 3 days, due to the volume of fluid infused. Mild or moderate pain, redness, swelling, or itching may occur at the site of infusion and generally go away in a few hours. Local reactions are less likely after the first few infusions.
    • The most common side effects of HYQVIA are headache, fatigue, nausea, fever, and vomiting.
    • Antibodies to the hyaluronidase component of HYQVIA were formed in some patients taking HYQVIA. It is not known if there is any long term effect. In theory, these antibodies could react with your body’s own PH20. PH20 is present in the male reproductive tract. So far, these antibodies have not been associated with increased or new side effects.

    These are not all the possible side effects with HYQVIA. Talk to your healthcare professional about any side effects that bother you or that don’t go away.

    Before starting HYQVIA, tell your healthcare professional if you:

    • Have or had any kidney, liver, or heart problems or history of blood clots because HYQVIA can make these problems worse.
    • Have IgA deficiency or a history of severe allergic reactions to IgG or other blood products.
    • Are pregnant, trying to become pregnant or are breast feeding.

    You are encouraged to report suspected side effects by contacting FDA at 1-800-FDA-1088 or www.fda.gov/medwatch or Shire Drug Safety at 1-800-999-1785.

    The risk information provided here is not comprehensive. To learn more, talk about HYQVIA with your healthcare provider or pharmacist.

    Please see the FDA-approved patient labeling